Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin - Wikidata - awgldk - TriplyDB

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

http://www.wikidata.org/entity/Q33822272

about

Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.Thromboxane and the thromboxane receptor in cardiovascular disease.Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.The pulmonary physician and critical care. 4. A new look at the pulmonary circulation in acute lung injury Prostacyclin biosynthesis and reduced 5-HT uptake after complement-induced endothelial injury in the dog isolated lung Endotoxin-induced shock in the rat. A role for C5a C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes.Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif.Enhanced release of thromboxane A(2) after exposure of human airway epithelial cells to meconium.Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension.Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium.Cyclooxygenase metabolites contribute to oleic acid-induced lung edema by a pressure effect.Sexual dimorphism in prostanoid-potentiated vascular contraction: roles of endothelium and ovarian steroids.Inducible nitric oxide synthase inhibition reverses pulmonary arterial dysfunction in lung transplantation.The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep.

P2860

Q33681740-4D3ADB92-24DF-4C13-9A95-8987E91F112A Q33899567-314596DD-83AA-4F03-852E-BA10EE6BF847 Q34572515-E313138C-2481-43E7-86AE-D5414542670A Q35532865-A2734E2F-F87B-4595-8C98-C7C71FA05926 Q35755432-DC4630F8-49C7-41A0-8F0E-D60F0CE03813 Q35816751-48F8A90C-61AB-40D4-8EE4-5A19C4B366A4 Q35856148-032EAC0B-FC2E-4D16-81CD-F61C83519ADC Q36822598-BC0C35AA-9A95-42D5-8168-41C07CA9CD8A Q40756072-32C22FC6-CC76-4E39-93B8-96F7F2F8DD55 Q40829916-EDCC4BED-136F-4ECA-9612-65926A27268F Q40926236-45A882E0-B972-47AF-B38A-168937C7AF5A Q41788328-3EE63CFE-5DEF-4997-99E3-B7E528045F72 Q44183043-BBC47775-2FEF-4CB0-AF8C-28BB93C5BCD2 Q46902224-AD0DCF74-24A3-4527-88A1-9E4098D2DEEE Q54274629-B5D32E26-07A8-401C-BBFB-F2E6F5D5BA44

P2860

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

http://www.wikidata.org/entity/Q33822272

description

1983 nî lūn-bûn

@nan

1983 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1983 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1983年の論文

@ja

1983年論文

@yue

1983年論文

@zh-hant

1983年論文

@zh-hk

1983年論文

@zh-mo

1983年論文

@zh-tw

1983年论文

@wuu

name

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

@ast

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

@en

type

label

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

@ast

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

@en

prefLabel

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

@ast

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

@en

P1433

Q33822272-31E233FF-DC3E-4E3E-A1C4-6CE4F8822790

P1476

Q33822272-55454C60-B30C-4032-B6D1-DE1AA9CA3355

P2093

Q33822272-03505DCB-5511-4330-B5B8-47409FF13F30

Q33822272-1BB74F62-0276-4EE8-ABA9-C53778634B6F

Q33822272-1F299BC6-4B29-45C0-8B25-27E6898D13F3

Q33822272-4AD9D686-09F6-47BA-83CE-30F86862971E

Q33822272-798B935F-9A8F-4558-97F7-147431A37F12

P2860

Q33822272-0BEC539B-528D-46C2-9A2B-DB2B433563E7

Q33822272-122579E6-6466-46E6-B576-F7F8995B1B62

Q33822272-175F06DA-CF56-4EAC-9C8B-9D52E00AE2F2

Q33822272-1A8B99CC-DDBB-4272-AFCF-EF4B5975E9D4

Q33822272-3BFD981D-13F5-405D-98A0-2A01BA3B556A

Q33822272-407DE568-A58E-4771-9785-D9A6E7E331E9

Q33822272-42D20C28-023D-44BC-A887-6443EC6A7531

Q33822272-4868696B-D4C9-49A2-9A2D-54CB5FAA8B66

Q33822272-69B64188-31A5-46FA-8829-860F4444874D

Q33822272-7227A110-D7A3-4B3C-B3C3-A20BD5036FB7

P304

Q33822272-D10C2692-B408-4467-99E5-FE4C9F28695F

P31

Q33822272-F938B745-4ABE-4D47-AE8E-9F9840662824

P356

Q33822272-F69F118C-E1A6-45DE-A53C-1CC419987246

P407

Q33822272-69023E87-D795-460A-9F64-8E8D3923619E

P433

Q33822272-2DB3F1E6-BCBB-43BD-AD60-6B030E178C7E

P478

Q33822272-176DD68F-020C-4F8A-8449-57B99B9F9646

P577

Q33822272-FE6A3B3A-4C9E-4D8F-927F-2C2293FD38B6

P698

Q33822272-440879F2-F795-49BC-A906-C6F8B8E81213

P921

Q33822272-6053F68E-FBDB-4B31-BAE5-83BADA1613D1

Q33822272-85681B8D-14AC-469B-9500-B139129F1E85

P932

Q33822272-F4826255-8424-4F0D-ADE3-ED9C89C3B590

P356

P1433

Journal of Clinical Investigation

P1476

Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin

@en

P2093

B Nadir

http://www.w3.org/2001/XMLSchema#string

J Harlan

http://www.w3.org/2001/XMLSchema#string

J Hildebrandt

http://www.w3.org/2001/XMLSchema#string

L Harker

http://www.w3.org/2001/XMLSchema#string

R Winn

http://www.w3.org/2001/XMLSchema#string

P2860

Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog.

Increased sheep lung vascular permeability caused by pseudomonas bacteremia

E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin

The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat.

Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.

Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep.

Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.

Altered lung metabolism of prostaglandins during hemorrhagic and endotoxin shock.

Acute respiratory failure in the adult. 1.

The protective effect of sodium meclofenamate in experimental endotoxin shock.

P304

911-918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI111062

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

1983-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6886010

http://www.w3.org/2001/XMLSchema#string

P921

vasoconstriction

P932

1129256

http://www.w3.org/2001/XMLSchema#string